| abstract |
The present invention provides a heterocyclic compound serving as a GLS1 inhibitor. Specifically, the present invention provides a compound as represented by formula (II), or an optical isomer, a pharmaceutically acceptable salt, a prodrug, a deuterated derivative, a hydrate, and a solvate thereof. The compound has GLS1 inhibitory activity, and can be used as a therapeutic agent for diseases or disorders related to GLS1. |